The sFasL (soluble FasL) levels of sera in patients with Stevens-Johnson syndrome or toxic epidermal necrolysis are significantly increased before development of skin detachment, mucosal lesions, or both [37]. This evidence concerns the gene FASLG and Stevens-Johnson syndrome.